Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status

Journal of the National Cancer Institute

Volumn 99, Issue 6, 2007, Pages 475-486

  Touillaud, Marina S ^a   Thiébaut, Anne C M ^a   Fournier, Agnès ^a   Niravong, Maryvonne ^a   Boutron Ruault, Marie Christine ^a   Clavel Chapelon, Françoise ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENTERODIOL; ENTEROLACTONE; ESTROGEN RECEPTOR; ISOFLAVONE; LIGNAN; MATAIRESINOL; PHYTOESTROGEN; PINORESINOL; PROGESTERONE RECEPTOR; SECOISOLARICIRESINOL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIETARY INTAKE; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; FRANCE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RISK ASSESSMENT; RISK REDUCTION; SOYBEAN; BREAST TUMOR; CHEMISTRY; DIET; FEEDING BEHAVIOR; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAGET NIPPLE DISEASE; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DIET SURVEYS; FEMALE; FOLLOW-UP STUDIES; FOOD HABITS; FRANCE; HUMANS; LIGNANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 34047253936     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk096     Document Type: Article

References (65)

1. Tham DM, Gardner CD, Haskell WL. Clinical review 97: Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998; 83:2223-35.
2. Deapen D, Liu L, Perkins C, Bernstein L, Ross RK. Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer 2002;99:747-50.
3. Ziegler RG, Hoover RTNT, Pike MC, Hildesheim A, Nomura AM, West DW, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-27.
4. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006;98:459-71.
5. McCann SE, Muti P, Mato D, Edge SB, Trevisan M, Freudenheim JL. Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. Int J Cancer 2004;111:440-3.
6. Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, Overvad K, et al. Plasma enuerolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol Biomarkers Prev 2004;13:2084-9.
7. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991;16:43-52.
8. Hulten K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G. An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 2002;41:168-76.
9. Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698-708.
10. Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, Koenig KL, Kato I, Arslan AA, et al. Circulating enterolactone and risk of breast cancer: A prospective study in New York. Br J Cancer 2004;91:99-105.
11. den Tonkelaar I, Keinan-Boker L, van't Veer P, Arts CJ, Adlercreutz H, Thijssen JH, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:223-8.
12. Kilkkinen A, Virtamo J, Vartiainen E, Sankila R, Virtanen MJ, Adlercreutz H, et al. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 2004;108:277-80.
13. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997;350:990-4.
14. Pietinen P, Stumpf K, Mannisto S, Kataja V, Uusitupa M, Adlercreutz H. Serum enterolactone and risk of breast cancer: A case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 2001;10:339-44.
15. Boccardo F, Lunardi G, Guglielmini P, Parodi M, Murialdo R, Schettini G, et al. Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 2004;40:84-9.
16. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 2002; 11:815-21.
17. van Gils CH, Peeters PH, Bueno-de-Mesquita HB, Boshuizen HC, Lahmann PH, Clavel-Chapelon F, et al. Consumption of vegetables and fruits and risk of breast cancer. JAMA, 2005;293:183-93.
18. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003;78:559S-69S.
19. Gaudet MM, Britton JA, Kabat GC, Steck-Scott S, Eng SM, Teitelbaum SL, et al. Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status. Cancer Epidemiol Biomarkers Prev 2004;13:1485-94.
20. Malin AS, Qi D, Shit XO, Gao YT, Friedmann JM, Jin F, et al. Intake of fruits, vegetables and selected micronutrients in relation to the risk of breast cancer. Int J Cancer 2003;105:413-8.
21. Fung TT, Hu FB, Holmes MD, Rosner BA, Hunter DJ, Colditz GA, et al. Dietary patterns and the risk of postmenopausal breast cancer. Int J Cancer 2005;116:116-21.
22. Olsen A, Tjonneland A, Thomsen BL, Loft S, Stripp C, Overvad K, et al. Fruits and vegetables intake differentially affects estrogen receptor negative and positive breast cancer incidence rates. J Nutr 2003;133:2342-7.
23. Messina MJ. Legumes and soybeans: Overview of their nutritional profiles and health effects. Am J Clin Nutr 1999;70:439S-50S.
24. Low YL, Taylor JI, Grace PB, Dowsett M, Scollen S, Dunning AM, et al. Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions. Cancer Epidemiol Biomarkers Prev 2005;14:213-20.
25. Touillaud MS, Pillow PC,Jakovljevic J, Bondy ML, Singletary SE, Li D, et al. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer 2005;51: 162-9.
26. Kesse E, Boutron-Ruault MC, Clavel-Chapelon F. Regional dietary habits of French women born between 1925 and 1950. Eur J Nutr 2005; 44:285-92.
27. Riboli E. Nutrition and cancer: Background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol 1992;3:783-91.
28. Ferrati P, Slimani N, Ciampi A, Trichopoulou A, Naska A, Lauria C, et al. Evaluation of under- and overreporting of energy intake in the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2002;5:1329-45.
29. van Liere MJ, Lucas F, Clavel F, Slimani N, Villeminot S. Relative validity and reproducibility of a French dietary history questionnaire. Int J Epidemiol 1997;26 Suppl 1:S128-36.
30. Favier JC, Ireland-Ripert J, Toque C, Feinberg M. Répertoire Général des Aliments. Table de composition (composition tables). INRA, CIQUAL-REGAL, editors. 2nd ed. Paris (France): Tec & Doc Lavoisier, 1995.
31. Su.Vi.Max. Table de composition des aliments. Paris (France): Economica; 2006.
32. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997;29:95-120.
33. Keinan-Boker L, van der Schouw YT, de Kleijn MJ, Jacques PF, Grobbee DE, Peeters PH. Intake of dietary phytoestrogens by Dutch women. J Nutr 2002;132:1319-28.
34. de Kleijn MJ, van der Schouw YT, Wilson PW, Adlercreutz H, Mazur W, Grobbee DE, et al. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: The Framingham study. J Nutr 2001;131:1826-32.
35. Liggins J, Bluck LJ, Runswick S, Atkison C, Coward WA, Bingham SA. Daidzein and genistein contents of vegetables. Br J Nutr 2000;84:717-25.
36. Mazur W. Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab 1998;12:729-42.
37. Antignac JP, Cariou R, Le Bizec B, André F. New data regarding phytoestrogens content in bovine milk. Food Chem 2004;87:275-81.
38. Kiely M, Faughnan M, Wahala K, Brants H, Mulligan A. Phyto-oestrogen levels in foods: The design and construction of the VENUS database. Br J Nutr 2003;89 Suppl 1:808-13.
39. Milder IE, Arts IC, van de PB, Venema DP, Holtman PC. Lignan contents of Dutch plant foods: A database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 2005;93:393-402.
40. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA. Daidzein and genistein content of fruits and nuts. J Nutr Biochem 2000;11:326-31.
41. Willett W, Stampfer M. Implications of total energy intake for epidemiologic analyses. In: Willett W, editor. Nutritional epidemiology. 2nd ed. New York (TNM: Oxford University Press; 1998. p. 273-301.
42. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey-choice of the time-scale. Am J Epidemiol 1997;145:72-80.
43. Adlercreutz H, Fotsis T, Heikkinen R, Dwyer JT, Woods M, Goldin BR, et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 1982;320:1295-9.
44. Dai Q, Franke AA, Yu H, Shu XO, Jin F, Hebert JR, et al. Urinary phytoestrogen excretion and breast cancer risk: Evaluating potential effect modifiers endogenous estrogens and anthropometrics. Cancer Epidemiol Biomarkers Prev 2003;12:497-502.
45. Keinan-Boker L, van der Schouw YT, Grobbee DE, Peeters PH. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 2004;79:282-8.
46. Horn-Ross PL, Hoggatt KJ, West DW, Krone MR, Stewart SL, Anton H, et al. Recent diet and breast cancer risk: The California Teachers Study (USA). Cancer Causes Control 2002;13:407-15.
47. Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, Sakoda LC, et al. Phytoestrogen consumption and breast cancer risk in a multiethnic population: The Bay Area Breast Cancer Study. Am J Epidemiol 2001;154.434-41.
48. dos Santos Silva I, Mangtani P, McCormack V, Bhakta D, McMichael AJ, Sevak L. Phyto-oestrogen intake and breast cancer risk in South Asian women in England: Findings from a population-based case-control study. Cancer Causes Control 2004;15:805-18.
49. McCann SE, Kulkarni S, Trevisan M, Vito D, Nie J, Edge SB, et al. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat 2006;99:309-11.
50. Milder IE, Feskens EJ, Arts IC, Bueno-de-Mesquita HB, Hollman PC, Kromhout D. Intake of the plant lignans secoisolariciresinol, matairesinol, lariciresinol, and pinoresinol in Dutch men and women. J Nutr 2005; 135:1202-7.
51. Kilkkinen A, Valsta M Virtamo J, Stumpf K, Adlercreutz H, Pietinen P. Intake of lignans is associated with serum enterolactone concentration in Finnish men and women. J Nutr 2003;133:1830-3.
52. Meagher LP, Beecher GR. Assessment of data on the lignan content of foods. J Food Compost Anal 2000;13:935-47.
53. Begum AN, Nicolle C, Mila I, Lapierre C, Nagano k Fukushima K, et al. Dietary lignins are precursors of mammalian lignans in rats. J Nutr 2004;134:120-7.
54. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 1991;2:427-42.
55. Seo HS, Denardo DG, Jacquot Y, Laios I, Vidal DS, Zambrana CR, et al. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 2006;99:121-34.
56. Sathyamoorthy N, Wang TT. Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer 1997;33:2384-9.
57. Cui X, Schiff R, Arpino G, Osborne CK, Lee AV. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol 2005;23:7721-35.
58. Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, et al. Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/ neu cross-talk in ER/HER2-positive breast cancer. J Natl Cancer Inst 2004;96:926-35.
59. Keinan-Boker L, Peeters PH, Mulligan AA, Navarro C, Slimani N, Mattisson I, et al. Soy product consumption in 10 European countries: The European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutt 2002;5:1217-26.
60. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-63.
61. Schiff R, Osborne CK Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer. Breast Cancer Res 2005;7:205-11.
62. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003;51:3-30.
63. Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 2003;21: 28-34.
64. Yasui Y, Potter JD. The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control 1999;10: 431-7.
65. Key TJ, Allen NE, Spencer EA, Travis RC. The effect of diet on risk of cancer. Lancet 2002;360:861-8.